Filing Details
- Accession Number:
- 0001019687-15-000263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-20 14:33:40
- Reporting Period:
- 2015-01-15
- Filing Date:
- 2015-01-20
- Accepted Time:
- 2015-01-20 14:33:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1485003 | Eleven Biotherapeutics Inc. | EBIO | Pharmaceutical Preparations (2834) | 252025616 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1590442 | Partnership Limited Investment V3 Super Jafco | Otemachi First Square West Tower 11F, 1-5-1, Otemachi Chiyoda-Ku Tokyo, Japan M0 100-0004 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-01-15 | 700 | $12.00 | 2,114,726 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-15 | 99 | $12.19 | 2,114,627 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-15 | 1 | $12.25 | 2,114,626 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-15 | 100 | $12.30 | 2,114,526 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-15 | 800 | $12.50 | 2,113,726 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-16 | 4,100 | $12.00 | 2,109,626 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-16 | 100 | $12.01 | 2,109,526 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-16 | 100 | $12.01 | 2,109,426 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-16 | 100 | $12.04 | 2,109,326 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |